Show simple item record

dc.contributor.authorGoodman, Greg J
dc.contributor.authorMagnusson, Mark R
dc.contributor.authorCallan, Peter
dc.contributor.authorRoberts, Stefania
dc.contributor.authorHart, Sarah
dc.contributor.authorMcDonald, Cara B
dc.contributor.authorClague, Michael
dc.contributor.authorRudd, Alice
dc.contributor.authorBekhor, Philip S
dc.contributor.authorLiew, Steven
dc.contributor.authorMolton, Michael
dc.contributor.authorWallace, Katy
dc.contributor.authorCorduff, Niamh
dc.contributor.authorArendse, Sean
dc.contributor.authoret al.
dc.date.accessioned2020-08-21T00:59:57Z
dc.date.available2020-08-21T00:59:57Z
dc.date.issued2020
dc.identifier.issn1090-820X
dc.identifier.doi10.1093/asj/sjz312
dc.identifier.urihttp://hdl.handle.net/10072/396609
dc.description.abstractBackground: Hyaluronic acid fillers have a satisfactory safety profile. However, adverse reactions do occur, and rarely intravascular injection may lead to blindness. Currently there is no internationally recognized consensus on the prevention or management of blindness from hyaluronic acid filler. Objectives: The authors sought to give guidance on how to minimize the risk and optimize the management of this rare but catastrophic adverse reaction. Methods: A multinational group of experts in cosmetic injectables from multiple disciplines convened to review current best practice and develop updated consensus recommendations for prevention and bedside intervention if visual loss occurs after cosmetic injection of hyaluronic acid filler. Results: The consensus group provided specific recommendations focusing on the consenting process, prevention, and early management of visual impairment related to intravascular hyaluronic acid filler injection. Conclusions: Although visual loss due to filler injections is rare, it is important that both patient and physician be aware of this risk. In this paper the authors describe methods and techniques available to reduce the risk and also document suggested initial management should a clinician find themselves in this situation.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherOxford University Press
dc.publisher.placeUnited States
dc.relation.ispartofpagefrom1009
dc.relation.ispartofpageto1021
dc.relation.ispartofissue9
dc.relation.ispartofjournalAesthetic Surgery Journal
dc.relation.ispartofvolume40
dc.subject.fieldofresearchBiomedical and clinical sciences
dc.subject.fieldofresearchcode32
dc.titleA Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationGoodman, GJ; Magnusson, MR; Callan, P; Roberts, S; Hart, S; McDonald, CB; Clague, M; Rudd, A; Bekhor, PS; Liew, S; Molton, M; Wallace, K; Corduff, N; Arendse, S; Manoharan, S; Shamban, A; Heydenrych, I; Bhatia, AC; Peng, P; Pavicic, T; Kapoor, KM; Kosenko, DE, A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management, Aesthetic Surgery Journal, 2020, 40 (9), pp. 1009-1021
dcterms.licensehttp://creativecommons.org/licenses/by/4.0/
dc.date.updated2020-08-20T23:58:11Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2019 The Aesthetic Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorMagnusson, Mark
gro.griffith.authorLiew, Steven C.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record